JP Morgan Chase (JPM) has exhausted itself to the upside, and is poised to set up a shorting opportunity. We are watching for a lower high to form to raise the odds for reversal to acceptable levels. Our expectation is that this market will rally towards the $69 per share area, and show us the…

The Eurodollar vs. The U.S. Dollar (EUR/USD) has paid us for our patience. A double bottom has formed at the 1.100 level, and this raises up the odds for success to acceptable levels and allows us to finally upgrade this forecast to three diamonds.

The S&P 500 index proxy (SPY) has fully realized our forecast for price as it whipsawed this week down to test the blue zone. At this point it is only a 60/40 proposition for any more downside, so we believe it is time to take profits and sit on the sidelines until the odds shift…

Apple Inc (AAPL) continues to perform as forecast, and now the odds are high that wel will see the wave of selling that we have been waiting so patiently for…Next target is the $120 per share level, and once we get there we will update you with new power measurements so we can fine tune…

Pfizer (PFE) is showing some troubling signs of liquidity as it waffles and whipsaws near its recent lows. This action puts me into a defensive posture, and now seems like a great time to take partial profits and defend this position with a trailed stop in the $34.60-$34.75 area.